Results 251 to 260 of about 234,379 (321)

Rest–Activity Disturbances Correlate with Core Features in Dementia with Lewy Bodies

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Sleep–wake disturbances are a clinically important and poorly studied feature of dementia with Lewy bodies (DLB) due to the challenges of in‐laboratory polysomnography in this population. Objectives To compare rest–activity rhythms in DLB, Parkinson's disease (PD), and age‐matched controls using home‐based wrist actigraphy and ...
Jack Anderson   +7 more
wiley   +1 more source

Correlations between Dysphagia Severity Scale Scores and Clinical Indices in Individuals with Multiple System Atrophy

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Dysphagia significantly impacts prognosis in individuals with multiple system atrophy (MSA). While video‐based assessments are practical, their limited availability highlights the need for a simple tool such as the Dysphagia Severity Scale (DSS) in clinical practice.
Ryunosuke Nagao   +8 more
wiley   +1 more source

Serotonin Antagonists in Experimental and Clinical “Dumping”

open access: green, 1962
Lloyd P. Johnson   +3 more
openalex   +2 more sources

Antidopaminergic Medications and Clinical Changes in Measures of Huntington's Disease: A Causal Analysis

open access: yesMovement Disorders, EarlyView.
Abstract Background Antidopaminergic medications (ADM) are often used for symptom management of Huntington's disease (HD). Evidence from past research suggests that ADMs are associated with worse clinical outcomes in HD, but their impact on various domains remains underexplored.
Michal Geva   +5 more
wiley   +1 more source

NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian Efficacy

open access: yesMovement Disorders, EarlyView.
Abstract Background Levodopa‐induced dyskinesia (LID) in Parkinson's disease (PD) is associated with ‘false neurotransmitter’ release of dopamine from serotonin (5‐HT) neurons. NLX‐112 is a first‐in‐class, highly selective 5‐HT1A receptor agonist which counteracts LIDs in experimental PD models.
Per Svenningsson   +13 more
wiley   +1 more source

Serotonergic Mechanisms in Proteinoid-Based Protocells. [PDF]

open access: yesACS Chem Neurosci
Mougkogiannis P, Adamatzky A.
europepmc   +1 more source

Molecular‐Informed Network Analysis Unveils Fatigue‐Related Functional Connectivity in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Fatigue in Parkinson's disease (PD) is a prevalent and debilitating non‐motor symptom. Despite its significant impact on quality of life, the underlying neurochemical and network‐based mechanisms remain poorly understood. Objectives This observational study applied a multimodal imaging approach to explore potential links between the
Ilaria Antonella Di Vico   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy